Vanda Pharmaceuticals (VNDA): Net earnings per share for the last 12 months

Symbol and logo of brand Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA) generates revenue from the sale of patented treatments for sleep disorders and schizophrenia. The trailing 12-month EPS reflects profitability trends, where -4.60 represents the metric's baseline. Patent protection shields margins from generics, while an academic approach to hiring neurobiologists with long-term options ensures sustainable business growth within the neuropsychiatry niche.

VNDA (Vanda) Net earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Analytical breakdowns and data insights for company Vanda Pharmaceuticals (VNDA)

- current quotes and average value forecast:
Price Chart Vanda Pharma|VNDA - Analyst Median Target
- stock exchange capitalization data:
Market Valuation Vanda Pharmaceuticals Inc.|VNDA - Total Enterprise Value
- balance sheet net asset value indicators:
Book Value per Share Vanda Pharmaceuticals|VNDA - Company Net Assets|Market Capitalization to Book Value Ratio vandapharma.com|VNDA - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Vanda Pharmaceuticals|VNDA - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio Vanda Pharmaceuticals|VNDA - Company Debts|Debts to Book Capitalization Vanda Pharma|VNDA - Company Long-Term Debts|Company Short-Term Debt Vanda Pharmaceuticals|Quick Ratio vandapharma.com
- net income and valuation multiples indicators:
VNDA - Company Profit|Projected Future Earnings Vanda Pharmaceuticals|VNDA - P/E Multiple|Projected Price to Earnings Vanda Pharmaceuticals Inc|VNDA - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vanda Pharma|VNDA - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Vanda Pharmaceuticals|VNDA - Earnings per share for the trailing year|Quarterly EPS earnings growth vandapharma.com|VNDA - Earnings growth in current year|Net earnings per share growth forecast for next year Vanda Pharmaceuticals
- revenue and sales details:
VNDA - Company Sales Revenue|Company Projected Revenue Vanda Pharma|VNDA - Market Cap to Revenue|Forward P/S Multiple Vanda Pharma
Fundamental company valuation:vandapharma.com (VNDA)
Mass-produced product of Vanda

Dynamic monitoring of earnings per share minimizes the risks of decision-making based on outdated quarterly data, which is critical for Vanda Pharmaceuticals (VNDA) given its stable scientific staff and protected patent portfolio. An analysis of fundamental TTM earnings per share allows for an assessment of the real efficiency of intellectual resource capitalization, dividing total net income by the number of securities to determine the true return on equity.

Competitors of Vanda Pharmaceuticals (VNDA)

ALKS - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Avadel Pharma AVDL|ATAI (atai.life) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months GH Research Corp (GHRS)|MNMD (mindmed.co) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months COMPASS Pathways plc (CMPS)|Net earnings per share (EPS TTM) LBRX|DRUG (Bright Minds Bio) - Earnings per share for the trailing year|Earnings per share for the last twelve months Cybin CYBN|Alto Neuro (ANRO) - Net earnings per one share for the last twelve months|NRXP - Earnings per share for the last twelve months|cingulate.com (CING) - Net earnings per share for the last 12 months|SILO: Net earnings per share (EPS TTM)|China Pharma Holdings Inc. - Earnings per share for the trailing year|CMND (Clearmind Medicine, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Psyence Bio PBM|Earnings per share for the last twelve months scisparc.com (SPRC)|Earnings per share for the last twelve months SEEL (seelostherapeutics.com)|Net earnings per share (EPS TTM) VRPX (Virpax Pharmaceuticals Inc.)|KRTX: Earnings per share for the last 12 months